Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

T-20 + efavirenz + protease inhibitors to be evaluated in HIV patients

March 20, 1998

Progenics' HIV products show promise in phase I/II clinical trials

March 20, 1998

Combivir approved in E.U.

March 19, 1998

Stavudine versus zidovudine therapy in HIV-1-infected pediatric patients

March 18, 1998

AIDS patients will have expanded access to Ziagen

March 17, 1998

Fortovase cited as preferred therapy in AIDS guidelines

March 17, 1998

p24-VLP safe but not immunogenic in phase II trials

March 17, 1998

Cel-Sci on the way to developing a worldwide AIDS vaccine

March 13, 1998

European academics collaborate on R&D of novel NNRTIs

March 12, 1998

Oxandrin approved in Russia

March 12, 1998

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...